The present invention discloses that imaging agents which comprise a specific type of matrix metalloproteinase inhibitors (MMPis) of the sulphonamide hydroxamate class labelled with an imaging moiety, are useful diagnostic imaging agents for in vivo imaging and diagnosis of the mammalian body.